Vitamin d study hopes to boost gut health in IBD patients
NCT ID NCT07177157
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study will give 150 adults with Crohn's disease or ulcerative colitis a daily 2000 IU vitamin D supplement for 12 months. Researchers want to see if patients stick with the supplement and whether it improves their quality of life. Participants will complete surveys, blood tests, and stool tests at the start, 6 months, and 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD-INFLAMMATORY BOWEL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Victoria Hospital - London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vitamin D3 (cholecalciferol) 2000 IU daily
What this could lead to
If successful, this could show that daily vitamin D is a simple, safe way to improve quality of life for people with inflammatory bowel disease.
What could go wrong
This is a small, early-phase study focused on adherence and blood levels, not on curing or controlling the disease itself. The results may not apply to all IBD patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.